Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

Item
http://www.wikidata.org/entity/Q24634033
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsCombination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and childrenRegular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse eventsβ(2) -adrenoceptor agonists: current and future directionEfficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trialEffects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPDEfficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma.Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary dMometasone furoate/formoterol in the treatment of persistent asthma.Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids.Emerging drugs for asthma.An update on bronchodilators in Phase I and II clinical trials.A review of mometasone furoate / formoterol in the treatment of asthma.Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthmaComparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.Histopathological Analysis of the Effects of Corticosteroids on Vocal Cords: Experimental Study.
P2860

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

Item
http://www.wikidata.org/entity/Q24634033
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term safety of mometasone ...... atients with persistent asthma
@ast
Long-term safety of mometasone ...... atients with persistent asthma
@en
Long-term safety of mometasone ...... atients with persistent asthma
@nl
type
label
Long-term safety of mometasone ...... atients with persistent asthma
@ast
Long-term safety of mometasone ...... atients with persistent asthma
@en
Long-term safety of mometasone ...... atients with persistent asthma
@nl
prefLabel
Long-term safety of mometasone ...... atients with persistent asthma
@ast
Long-term safety of mometasone ...... atients with persistent asthma
@en
Long-term safety of mometasone ...... atients with persistent asthma
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Long-term safety of mometasone ...... atients with persistent asthma
@en
P2093
P2860
P304
P31
P356
10.3109/02770903.2010.514634
P407
P433
P478
P50
P577
P5875
P698
P921
P932